NEUREN PHARMACEUTICALS LIMITED
NEU - Further Validation of NNZ-2566 as a Traumatic Brain Injury Treatment - Mr David Clarke, CEO
Wed, 14 Feb 2007 01:30PM
Send a link for this presentation to a friend
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Wed, 14 Feb 2007
01:30PM Australia/NSW
Boardroom Radio Tools
Select a tab above to display more information
 ARANA THERAPEUTICS LIMITED
(AAH)
|
AAH - Full Year Results 2008 - Mr Robin Beaumont, Chairman and Mr Niall Henderson, CFO Thu, 13 Nov 2008 04:30PM |
    |
| CIRCADIAN TECHNOLOGIES LIMITED (CIR) |
Annual General Meeting Copmutershare Conference Centre, Yarra Falls, 452 Johnston St, Abbotsford, Melbourne, VIC
Fri, 14 Nov 2008 09:30AM 09:30AM Australia/Victoria |
|
| BONE MEDICAL LIMITED (BNE) |
Annual General Meeting Seminar Room 5, Technology Park Function Centre, 2 Brodie Hall Drive, Bentley, WA
Wed, 19 Nov 2008 07:30PM 04:30PM Australia/West |
|
NEUREN PHARMACEUTICALS LIMITED (NEU)
ASX code: NEU
Website: http://www.neurenpharma.com/
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Biopharmaceutical company with a focus on neuroprotection and metabolism.
Address:
122 Arthur Street, C/o Barnes Dowell James
NORTH SYDNEY
NSW
Phone: +64 9 529 3942
Fax: +64 9 529 3941
Executives & Directors
Dr Robin Congreve , Chairman
Dr Parmjot Bains , CEO
Mr Larry Glass , CEO
Mr Tom Amos , Non Exec. Director
Mr Trevor Scott , Non Exec. Director
Dr Douglas Wilson , Non Exec. Director
Dr Graeme Howie , Non Exec. Director
Mr Rob Turnbull , CFO
Mr Robert Waring , Company Secretary
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Please refer to the relevant stock exchange if any of the above information is incorrect
NEUREN PHARMACEUTICALS LIMITED (NEU) Events
| Company (Stock Code) | Date/Time | Event | Timezone: Australia/NSW |
|---|---|---|---|
|
Wed, 14 Feb 2007 01:30PM |
NEU - Further Validation of NNZ-2566 as a Traumatic Brain Injury Treatment - Mr David Clarke, CEO |
   |
| Fri, 29 Aug 2008 | Interim Results | ||
| Thu, 29 May 2008 12:30PM |
Annual General Meeting HWL Ebsworth, Level 14, Australia Square, 264-278 George St, Sydney, NSW
|
||
| Fri, 29 Feb 2008 | Full Year Results | ||
| Fri, 12 Oct 2007 12:30PM 02:30PM Pacific/Auckland |
EGM Level 1, 103 Carlton Gore Road, Newmarket, Auckland
|
||
| Fri, 31 Aug 2007 | Interim Results | ||
| Wed, 23 May 2007 12:30AM |
Annual General Meeting Level 47, MLC Centre, 19 Martin Place Sydney NSW 2000
|
||
| Fri, 16 Mar 2007 | Full Year Results | ||
| Tue, 12 Sep 2006 | Interim Results | ||
| Wed, 3 May 2006 12:00AM |
Annual General Meeting NSW Trade & Investment Centre, Level 44, Grosvenor Place, 225 George Street Sydney NSW 2000
|
||
| Tue, 28 Feb 2006 | Full Year Results | ||
| Mon, 30 May 2005 12:30PM |
Annual General Meeting ASX Auditorium, 18-20 Bridge St, Sydney, NSW
|
||
NEUREN PHARMACEUTICALS LIMITED (NEU)
| Phase 3 trial data collection completed | Mon, 10 Nov 2008 |
| Appendix 4C - quarterly | Fri, 31 Oct 2008 |
| Neuren raises $2m through underwritten SPP | Tue, 30 Sep 2008 |
| Change of Director`s Interest Notice | Tue, 30 Sep 2008 |
| Appendix 3B | Tue, 30 Sep 2008 |
| US Army to provide additional NNZ2566 trial funding | Thu, 4 Sep 2008 |
| Half Yearly Report and Accounts | Fri, 29 Aug 2008 |
| Results of Special Shareholders` Meeting | Thu, 28 Aug 2008 |
| Neuren signs cancer license and collaboration agreement | Wed, 27 Aug 2008 |
| Neuren extends SPP closing date | Wed, 27 Aug 2008 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.
